CDE Exam 2021 Questions And Answers

CDE Exam 2021 Questions And Answers Biguanides Medication Names - ANS Metformin (Glucophage, Riomet (Liquid)) Metformin Extended Release (Glucophage XR, Fortamet, Glumetza) Biguanides Medication Action (oral) - ANS Decreases amount of glucose released from liver. lowers A1c up to 2% Biguanides Possible Side Effects - ANS Bloating, gas, diarrhea, upset stomach, loss of appetite (usually within the first few weeks of starting). Take with food to minimize symptoms. Metformin is not likely to cause low blood glucose. In rare cases, lactic acidosis may occur in people with abnormal kidney or liver function. Metformin increases the sensitivity of insulin Sulfonylureas Medication Action (oral) - ANS Stimulates the pancreas to release more insulin, both right after a meal and then over several hours Sulfonylureas Medication Names - ANS Glimepiride (Amaryl) Glyburide (Diabeta, Micronase) Glipizide (Glucotrol, Glucotrol XL) Micronized Glyburide (Glynase) lower a1c up to 2% Sulfonylureas Possible Side Effects - ANS Low blood glucose, occasional skin rash, irritability, upset stomach Meglitinides & D-Phenylalanine Derivatives Medication Action (oral) - ANS Stimulate the pancreas to release more insulin right after a meal. Meglitinides & D-Phenylalanine Derivatives Medication Names - ANS Repaglinide (Prandin) Nateglinide (Starlix) Meglitinides & D-Phenylalanine Derivatives Possible Side Effects - ANS Effects diminish quickly and they must be taken with each meal; may cause low blood glucose Thiazolidinediones Pioglitazone (TZDs) Medication Action (oral) - ANS Makes the body more sensitive to the effects of insulin. Increases the amount of glucose taken up by muscle cells and keeps the liver from overproducing glucose Thiazolidinediones Pioglitazone (TZDs) Medication Names - ANS Pioglitazone(Actos) Rosiglitazone (Avandia) Thiazolidinediones Pioglitazone (TZDs) Possible Side Effects - ANS May cause side effects such as swelling (edema) or fluid retention. Do not cause low blood sugar when used alone. Increased risk of congestive heart failure in those at risk. mobilize visceral fat and promote deposition in sub q adipose tissue Dipeptidl Peptidase 4 Inhibitors (DPP-4) Medication Action (oral) - ANS Incretin tells your body to release insulin after you eat. After the insulin is released, an enzyme called DPP-4 removes the incretin from the body- these inhibit DPP-4 removal so incretin stays and triggers more insulin to be released Dipeptidl Peptidase 4 Inhibito